Cargando…
CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT
CD155 is a shared ligand for activating and inhibitory immunoreceptors DNAX accessory molecule 1 (DNAM‐1), also called CD226, and T cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory motif domain (TIGIT), which are expressed on natural killer (NK) cells and T cells, and positively and...
Autores principales: | Matsuo, Tomohei, Iguchi‐Manaka, Akiko, Shibuya, Akira, Shibuya, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633295/ https://www.ncbi.nlm.nih.gov/pubmed/35947095 http://dx.doi.org/10.1111/cas.15526 |
Ejemplares similares
-
Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
por: Nagumo, Yoko, et al.
Publicado: (2014) -
Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
por: Okumura, Genki, et al.
Publicado: (2020) -
High expression of soluble CD155 in estrogen receptor-negative breast cancer
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2019) -
Increased Soluble CD155 in the Serum of Cancer Patients
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2016) -
Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma
por: Nakazawa, Tadao, et al.
Publicado: (2022)